Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Polymenorrhoea should be included in PCOS diagnostic criteria due to similar metabolic issues.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

Anti-androgens are effective for female acne but less so for male-pattern hair loss, with side effects similar to birth control pills.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Polycystic ovary syndrome (PCOS) lowers women's quality of life, especially mentally and socially, but nursing guidelines can improve their understanding of the condition.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Removing both ovaries treated the woman's excess male hormone symptoms.

Ovarian hyperthecosis can cause polycythemia, and surgery can normalize symptoms.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Finasteride safely reduces excessive hair growth in women.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Lifestyle changes improve symptoms and fertility in hyper-androgenic women.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

The conclusion is that there's a need for a new conference to establish stricter guidelines for diagnosing Polycystic Ovary Syndrome (PCOS).